Patient Positioning for Treatment of Proximal Ureteral Stones
ConditionUreteral Stone
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIcahn School of Medicine at Mount Sinai
About this trial
Ureteroscopic management of proximal ureteral stones presents technical challenges including stone retropulsion, prolonged operative time, and conversion to intrarenal treatment. Reverse Trendelenburg positioning has been shown to reduce proximal stone migration and operative time in ureteral stones, while the T-tilt position improves intrarenal stone clearance. The optimal strategy for proximal ureteral stones (treating stones in situ using reverse Trendelenburg versus pushing stones into the kidney followed by intrarenal treatment in T-tilt) remains unknown.
This randomized controlled trial compares these two strategies, with primary focus on operative time as a measure of procedural efficiency.
A total of 54 patients (27 per arm) will be enrolled at Mount Sinai West.
Eligibility criteria
Qualifiers
Adults aged 18 years and older.
Diagnosed with kidney stones and scheduled for fURS.
Stone burden > 1 cm and/or multiple stones will be eligible.
Able and willing to provide informed consent.
Disqualifiers
Pregnant persons as determined by pre-operative urine pregnancy test (standard of care at the institution)
Untreated UTI
Patients with urinary anomalies (e.g., urinary diversion, ureteral reconstruction, horseshoe kidney)
Single stone < 1 cm
Trial design
Treatments tested in this trial
- Reverse Trendelenburg Position
- T-Tilt Position
Treatment groups
54 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov